Pharmacokinetics of an anti-human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjects - Zhang, R; Yan, J; Shahinian, H K; Shahinian, H; Amin, G; Lu, Z; Liu, T; Saag, M S; Jiang, Z; Temsamani, J; Martin, R R (Clinical pharmacology and therapeutics, 1995)
Keywords: Adult; Antiviral Agents - adverse effects; Antiviral Agents - pharmacokinetics; Antiviral Agents - urine; Base Sequence; Chromatography, High Pressure Liquid; Electrophoresis, Polyacrylamide Gel; HIV Infections - drug therapy; HIV Infections - metabolism; HIV Infections - urine; Humans; Infusions, Intravenous; Male; Molecular Sequence Data; Oligodeoxyribonucleotides, Antisense; Oligonucleotides, Antisense - adverse effects; Oligonucleotides, Antisense - pharmacokinetics; Oligonucleotides, Antisense - urine; Sulfur Radioisotopes; Thionucleotides - adverse effects; Thionucleotides - pharmacokinetics; Thionucleotides - urine; Tissue Distribution